Loading clinical trials...
Loading clinical trials...
Endothelial Glycocalyx Status and Damage in Brain Death Organ Donors
The study aims the assessment of endothelial glycocalyx (EG) degradation in deceased organ donors. There is a lack of organs for the transplantation program. By the description of the EG status, we can open room for organ optimization before transplantation and improve the organ function after transplantation in marginal donors.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital Hradec Kralove
Hradec Králové, Czechia
Start Date
January 1, 2022
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2025
Last Updated
March 27, 2025
100
ESTIMATED participants
Endothelial glycocalyx damage assessment
DIAGNOSTIC_TEST
Lead Sponsor
University Hospital Hradec Kralove
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions